SMN2 and proximal spinal muscular atrophy: There are also genome-editing strategies for correcting the SMA phenotype, for example, using a genome-editing strategy for the Cas9-mediated disruption of splicing-regulatory elements (SREs) located in intron 7 of SMN2: ISS (intronic splicing silencer)-N1 and ISS + 100.